510(k) Report

510(k) · Cleared

Cleared

CT-Mass

K033774510(k) TraditionalCleared Mar 2, 200490-day reviewClass II21 CFR 892.1750

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medis Medical Imaging Systems BV · JAK System, X-Ray, Tomography, Computed

Cleared on Mar 2, 2004 as substantially equivalent to K013422 (GE Medical Systems, 2001) and 1 other predicate after a 90-day review. Its family tree reaches back 2 generations to 2000.

Decided
Mar 2, 2004
Review
90 days
Class
Class II
Product code
JAK
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K000315 (2000). 4 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2002: 1 other ancestor2000: 1 other ancestorK000315 · Ventricular Analysis Toolkit Option · GE Medical Systems · 2000K013422 · Cardiq Function · GE Medical Systems · 20012000200220042006
Other ancestors, by generation 1 generation back: 1 other ancestor2 generations back: 1 other ancestor K013422 · Cardiq Function · GE Medical Systems · 2001K000315 · Ventricular Analysis Toolkit Option · GE Medical Systems · 20000
  1. Root · 2 generations backK000315 Ventricular Analysis Toolkit OptionGE Medical Systems · 2000
  2. 1 generation backK013422 Cardiq FunctionGE Medical Systems · 2001
  3. This deviceK033774 CT-MassMedis Medical Imaging Systems BV · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K000315Ventricular Analysis Toolkit OptionGE Medical Systems2000—
−1K013422Cardiq FunctionGE Medical Systems2001—
0 (this device)K033774CT-MassMedis Medical Imaging Systems BV2004—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010
200210
FIG. 1 — Lineage of K033774, 2000–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAK device

  1. #1 K230223 iCAC Devicescore 23.5 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K013422Cardiq Function
Summary page 1
…vice Class. Narne Computed Tomography x-ray systems Regulation Number 21 CFR 892.1750 (90 JAK; Class II) 3. Predicate Device(s) GEMS: 510(k) K013422; K020796 4. Description of the device: CT-MASS is a professional state-of-the-art analytical software tool designed for UNIX, L…
GE Medical Systems2001—
*K020796Card IQ Analysis II
Summary page 1
…s. Narne Computed Tomography x-ray systems Regulation Number 21 CFR 892.1750 (90 JAK; Class II) 3. Predicate Device(s) GEMS: 510(k) K013422; K020796 4. Description of the device: CT-MASS is a professional state-of-the-art analytical software tool designed for UNIX, Linux as w…
GE Medical Systems2002—

Also cleared against K013422: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 2 companies; a new generation was cleared every 2.3 years on median.
  • None of the 4 ancestors has a recall.
  • 5 other devices also cite its predicate K013422.

How does its category compare?

All JAK devices

JAK System, X-Ray, Tomography, Computed: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JAK

27in 2025

2007: 142008: 262009: 152010: 72011: 162012: 282013: 172014: 302015: 302016: 252017: 292018: 242019: 282020: 302021: 202022: 302023: 272024: 262025: 272026 (partial year): 21
2007high 30 (2014) · low 7 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAK

141in 2025

2007: 27 days median2008: 42 days median2009: 31 days median2010: 92 days median2011: 155 days median2012: 121 days median2013: 132 days median2014: 200 days median2015: 140 days median2016: 129 days median2017: 96 days median2018: 114 days median2019: 94 days median2020: 112 days median2021: 145 days median2022: 131 days median2023: 139 days median2024: 141 days median2025: 141 days median2026 (partial year): 167 days median
2007high 200 (2014) · low 27 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAK

17in 2025

2007: 112008: 162009: 292010: 512011: 342012: 232013: 112014: 102015: 282016: 442017: 332018: 102019: 52020: 82021: 152022: 92023: 92024: 202025: 172026 (partial year): 23
2007high 51 (2010) · low 5 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAK

219in 2025

2007: 762008: 1202009: 1052010: 1192011: 2052012: 1922013: 4142014: 3082015: 4542016: 3652017: 3382018: 5432019: 2332020: 1772021: 2612022: 1992023: 3102024: 2122025: 219
2007high 543 (2018) · low 76 (2007)2025

MAUDE reports naming product code JAK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200714271176
2008264216120
2009153129105
201079251119
20111615534205
20122812123192
20131713211414
20143020010308
20153014028454
20162512944365
2017299633338
20182411410543
201928945233
2020301128177
20212014515261
2022301319199
2023271399310
20242614120212
20252714117219
20262116723—

What is it indicated for?

CT-MASS has been developed for the objective and reproducible analysis of multi-slice, multi-phase left and right ventricular function from cardiac CT data sets. The itended purposes are:

1. Supporting clinical diagnoses about the status of the global and regional function and anatomy of the human heart;

2. Supporting the subsequent clinical decision making processes;

3. Supporting the use in clinical research trials, directed at studying changes in function and anatomy of the heart chambers as a result of treatment.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K033774: CT-Mass.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K033774

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026